uk 68798 has been researched along with Coronary Disease in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leung, TK; Nattel, S; Rivard, L; Schram, G; Shiroshita-Takeshita, A; Sinno, H | 1 |
| Burke, P; Khawaja, O; Machado, C; Sekulic, M; Serafimovski, N | 1 |
| Montero, M; Schmitt, C | 1 |
| Le Jemtel, TH | 1 |
| Mortensen, E; Refsum, H; Yang, T | 1 |
| Bril, A; Gout, B; Jean, J | 1 |
| Cobbe, SM; Rasmussen, HS; Sedgwick, M; Walker, D | 1 |
1 trial(s) available for uk 68798 and Coronary Disease
| Article | Year |
|---|---|
Usefulness of dofetilide for the prevention of atrial tachyarrhythmias (atrial fibrillation or flutter) after coronary artery bypass grafting.
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Coronary Artery Bypass; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Follow-Up Studies; Humans; Incidence; Length of Stay; Male; Michigan; Phenethylamines; Postoperative Complications; Potassium Channel Blockers; Potassium Channels; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome | 2008 |
6 other study(ies) available for uk 68798 and Coronary Disease
| Article | Year |
|---|---|
The pharmacological response of ischemia-related atrial fibrillation in dogs: evidence for substrate-specific efficacy.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Calcium Channel Blockers; Coronary Disease; Diltiazem; Dogs; Electric Stimulation; Flecainide; Models, Animal; Nadolol; Phenethylamines; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sulfonamides; Vagus Nerve | 2007 |
Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents D-sotalol and dofetilide.
Topics: Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Heart; Heart Ventricles; Humans; In Vitro Techniques; Membrane Potentials; Phenethylamines; Sotalol; Sulfonamides | 1996 |
Management of heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Atrial Fibrillation; Coronary Disease; Heart Failure; Humans; Myocardial Revascularization; Phenethylamines; Ramipril; Randomized Controlled Trials as Topic; Sulfonamides; Ventricular Dysfunction, Left | 2000 |
Class III antiarrhythmic action and inotropy: effects of dofetilide in acute ischemic heart failure in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Coronary Disease; Dogs; Electrocardiography; Female; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Phenethylamines; Stimulation, Chemical; Sulfonamides | 1992 |
Comparative effects of a potassium channel blocking drug, UK-68,798, and a specific bradycardic agent, UL-FS 49, on exercise-induced ischemia in the dog: significance of diastolic time on ischemic cardiac function.
Topics: Animals; Anti-Arrhythmia Agents; Benzazepines; Cardiovascular Agents; Coronary Disease; Dogs; Electrocardiography; Female; Heart; Heart Rate; Male; Myocardial Contraction; Phenethylamines; Physical Conditioning, Animal; Potassium Channels; Sulfonamides | 1992 |
Pharmacokinetic and pharmacodynamic effects of UK-68,798, a new potential class III antiarrhythmic drug.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Coronary Disease; Electrocardiography; Female; Half-Life; Heart Rate; Humans; Male; Middle Aged; Phenethylamines; Sulfonamides | 1991 |